Preclinical imaging research
The power of non-invasive, in vivo imaging for novel drug discovery from lead optimization to clinical study was recognized by pharmaceutical industry leaders. HMII provides one-stop imaging services for customers.
● Biodistribution and pharmacokinetic research
● Mechanism of action and pharmacodynamic research
● Receptor occupancy research
● Blood Brain Barrier (BBB) penetration research
● Drug-drug interactions and drug safety research
● Immuno-PET research
Whole-body biodistribution of cancer models
Animal tissues specific uptake